Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

What's Going On With Novavax Stock Today?

Published 09/01/2023, 15:26
Updated 09/01/2023, 16:41
© Reuters.  What's Going On With Novavax Stock Today?
NVAX
-

Benzinga - Novavax Inc (NASDAQ: NVAX) shares are trading higher Monday after the company announced a CEO transition.

What Happened: Novavax said John Jacobs will succeed Stanley Erck as president and CEO, as well as a member of the company's board of directors, effective Jan. 23. Erck will serve as an advisor for the next 15 months to enable a smooth transition.

"Stan led Novavax from a clinical development organization to a global commercial vaccines company during a worldwide pandemic. This foundation puts Novavax in a strong position to execute on its long-term strategy, and we look forward to supporting Stan and John through the transition," said James Young, chairman of the board.

Jacobs will join Novavax from Harmony Biosciences, where he served as president and CEO and a member of the board since June 2018.

Novavax is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.

NVAX Price Action: Novavax has a 52-week high of $137.66 and a 52-week low of $8.75.

The stock was up 9.39% at $12.06 at time of publication, according to Benzinga Pro.

Photo: Jernej Furman from Flickr.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.